FDA Drug Recalls

Recalls / Class III

Class IIID-1518-2019

Product

Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-545-01

Brand name
Nystatin And Triamcinolone Acetonide
Generic name
Nystatin And Triamcinolone Acetonide
Active ingredients
Nystatin, Triamcinolone Acetonide
Route
Topical
NDC
68180-545
FDA application
ANDA208205
Affected lot / code info
Lot #: K800245, Exp. Dec 2019; K900036 Exp. Sep 20; K900153, Exp. 09/2020

Why it was recalled

Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.

Recalling firm

Firm
Lupin Pharmaceuticals Inc.
Manufacturer
Lupin Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
111 S Calvert St Fl 21ST, N/A, Baltimore, Maryland 21202-6174

Distribution

Quantity
33,939 tubes
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2019-07-17
FDA classified
2019-07-25
Posted by FDA
2019-07-31
Terminated
2020-09-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1518-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Nystatin And Triamcinolone Acetonide · FDA Drug Recalls